Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe website’s ClinicalTrials.gov footer was updated from revision v3.5.2 to v3.5.3, indicating a platform release/version update.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded 'State of Vienna' as the location designation and updated Vienna addresses to 'Vienna, State of Vienna, Austria, 1030' and '1090', replacing the previous 'Vienna' entries. Also updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. The study details and page layout appear unchanged.SummaryDifference0.0%

- Check55 days agoChange Detected- Revision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This appears to be a versioning update to the documentation with no changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.